Skip to content

Cognitive-Behavioral Therapy for Adults With ADHD: A Qualitative Study

Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation: A Qualitative Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05037903
Enrollment
14
Registered
2021-09-08
Start date
2021-07-01
Completion date
2022-08-31
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder

Brief summary

This is a qualitative study of participants who have taken part in a randomized controlled trial (RCT) of a new treatment protocol based on cognitive-behavioral therapy for adults with attention deficit/hyperactivity disorder predominantly inattentive presentation. The purpose of the qualitative study is to explore participant perceptions of taking part in the RCT to further develop and improve the new treatment protocol.

Interventions

BEHAVIORALCognitive-behavioral therapy

Cognitive and behavioral interventions aimed at increasing behavioral activation, and reducing procrastination and inattentive symptoms.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Principal diagnosis of ADHD inattentive presentation * 18 years of age or older * If on medication, it needs to be well-established since three months, and * Prior psycho-educational intervention

Exclusion criteria

* Intellectual impairment * Substance use disorder * Difficulties in adherence to medical or other treatment * Social and/or psychiatric problems to such an extent that they prevent focusing on treatment, or * Simultaneous psychological treatment

Design outcomes

Primary

MeasureTime frameDescription
Qualitative interview data45-60 minutesParticipant responses based on questions posed in an interview

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026